Navigation Links
Inspiration Biopharmaceuticals Announces Filing of IND for Novel Recombinant Factor IX Product, IB1001, for the Treatment of Hemophilia B
Date:11/13/2007

LAGUNA NIGUEL, Calif., Nov. 13 /PRNewswire/ -- Inspiration Biopharmaceuticals announced today that it has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) to begin clinical trials with IB1001, an intravenous recombinant Factor IX (rFIX) product for the on demand and prophylactic treatment of the bleeding disorder associated with hemophilia B.

Upon FDA approval of the IND application, Inspiration Biopharmaceuticals intends to enter Phase 1/2 clinical trials to evaluate the pharmacokinetics (PK) and safety profile of IB1001, compared with the commercially available Factor IX products; rFIX, BeneFix(R) and plasma-derived Factor, MonoNine(R). Following successful completion of the PK phase of this study, patients will then enroll in one of two trials: a six month Phase 1/2 On Demand trial to document safety and efficacy in treating spontaneous bleeding episodes or a pivotal Phase 2/3 Prophylaxis trial to document safety and efficacy in the prevention of spontaneous bleeding. In addition, the safety and efficacy of peri-surgical prophylactic administration of IB1001 to control bleeding during surgical procedures will be evaluated. The rate of inhibitor formation will be evaluated throughout all phases of the clinical investigation of IB1001.

"We are excited to be filing an IND for IB1001," said Michael Griffith, Ph.D., President and CEO, Inspiration Biopharmaceuticals. "Preclinical studies have demonstrated the expected PK and safety profile for IB1001 when compared to the clinically proven commercial Factor IX products. Our cost-effective manufacturing platform for Factor IX positions Inspiration to expand the global supply of i.v. rFIX and to develop next generation products to facilitate prophylactic care of the hemophilia B patients worldwide. Our ultimate goal is to leverage our low cost manufacturing technology to find the means for non-invasive delivery of Factor IX which we believe may represe
'/>"/>

SOURCE Inspiration Biopharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3

Related medicine technology :

1. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
2. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
3. Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months
4. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
5. Morria Biopharmaceuticals Plc Initiates Phase I Clinical Study of MRX-4 in Allergic Rhinitis
6. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
7. Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
10. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
11. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., , RANCHO CORDOVA, Calif., Nov. 25 /PRNews...ary of American Pacific Corporation (Nasdaq: APFC...tal Responsibility and Sustainability Award at the...by the California Manufacturers and Technology Ass...ciation (IEA) and the Chemical Industry Council of...
(Date:11/25/2009)..., , NEW YORK, Nov. 25 ...arch report is available in its catalogue: ,, ...ve ,, http://www.reportlinker.com/p0164330/M....html ,, Rising incidence of breast cancer in ...principal factor influencing growth in the mammogr...
(Date:11/25/2009)..., , SAN DIEGO, Nov. 25 /PRNewswire-...edical device company focused on developing produc...r the spine, announced today that it will host a c...30 p.m. ET / 2:30 p.m. PT. The conference call wi...nt for the Company,s products and will include com...
Breaking Medicine Technology:AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Reportlinker Adds Mammography Equipment - A Global Market Perspective 8NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3NuVasive Announces Conference Call and Webcast Regarding Reimbursement 4Arena Pharmaceuticals to Present at the UBS Global Life Sciences Conference 14150 1Arena Pharmaceuticals to Present at the UBS Global Life Sciences Conference 14150 2Arena Pharmaceuticals to Present at the UBS Global Life Sciences Conference 14150 3Cheap quick bedside eye movement exam outperforms MRI for diagnosing stroke in patients 57673 1Cheap quick bedside eye movement exam outperforms MRI for diagnosing stroke in patients 57673 2Cheap quick bedside eye movement exam outperforms MRI for diagnosing stroke in patients 57673 3Guatemala Treatment Center Becomes First in Latin America to Introduce Fast and Precise RapidArc Radiotherapy Cancer Treatments 57669 1Guatemala Treatment Center Becomes First in Latin America to Introduce Fast and Precise RapidArc Radiotherapy Cancer Treatments 57669 2
...search reflects depth and breadth of, collaborati...atments for diverse forms o...f Zometa(R), the leading IV, bisphosphonate, on re...cer, - Four oral sessions to feature RAD001, firs...ncluding first results of RECORD-1 study in renal ...
...ith a newly cleared device to identify the, lipid...e associated with complications ...InfraReDx, Inc. today,announced that physicians at...ssfully used its LipiScan(TM) Coronary Imaging Sys...ion. This is the first patient in the,world in who...
Other Medicine Technology:Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 2Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 3Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 4Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 5Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 6Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 7Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 8Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 9Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 10First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 2First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 3First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 4
(Date:11/28/2009)...CHICAGO, Nov. 28 Get ready for ...n the clinical routine when Siemens introduces...bly and Annual Meeting of the Radiological Society...ber 3 at McCormick Place (Booth #825, East Buildin...go. via , Siemens, new imaging software for m...
(Date:11/28/2009)...ne variation believed to affect circadian rhythm,...) -- New research suggests that an internal body c...he development of bipolar disorder in children. ,...e genetic makeup of 152 children with bipolar diso...ood swings, and 140 children without the disorder....
(Date:11/27/2009)...EDFORD, Mass., Nov. 27 G... a supplier of precision technology products and s...al meeting of the Company,s shareholders has been ...d location of the meeting will be announced in due...eived a requisition notice from Stephen Bershad, a...
(Date:11/27/2009)... Biotech firm Replikins Ltd. today issu...us genomic data. It shows that the lethality of t...5) during the virus,s current outbreak in the spri...k of 2.0 (s.d. 0.1). The H1N1 infectivity count, h... Boston (PRWEB) November 27, 2009 -- Biotech fi...
(Date:11/27/2009)... FRANCISCO, Nov. 27 The ...at Blair Lambert, CFO/COO, will present at the NAS...at the May Fair Hotel in London, England, on Wedne...o listen to a live broadcast of The Gymboree Corpo...g on to www.gymboree.com, click on "Our Company" a...
Breaking Medicine News(10 mins):Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 2Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 3Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 4Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 5Health News:Bipolar Disorder May Be Tied to Body Clock 2Health News:GSI Group Calls Shareholders Meeting 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5
...s by tobacco companies have been blamed for a 45 p... the last eight years//, a media report said Monda...tics department show the number of women smokers j...from 726,300 to 678,900 in the same period. ...
...ospital's radiotherapy department to dogs and cats...and the conservatives//. To effectively mana...uggestions came in from the staff that a pets’ cli... made by the managers, the earnings from the Satur...
...at an 8-year decline in the smoking rate among the...at 21% in the last 2 years//. According to t...trol and Prevention, a lack of drop in smoking amo...tent with those of 2004 and 2005," Terry Pechacek,...
...d men show symptoms of depression, irascibility, a...ng interest// in sex because of the lack of testos...ed Thursday found that 52 percent of men between 3...conducted by the Beijing University Centre for Men...
...ject in Britain has a new companion. A recent repo...re combating eating disorders//, either anorexia o...he government has instructed most of the general p...euphoria about fancy diets for the elusive ‘hour g...
...nravel the effect of behavioral counseling on in...sions of counseling// that focuses on good sleep h... sleeping well. During sessions therapists aim...individuals in their effort to find rest and to sl...
Other Medicine News:Health News:Pet Peeves: Conservatives Howl at Proposal to Share NHS Hosp by Pets and People 2Health News:Drop in smoking rate stalls 2
Wraparound Apron & Vest
Coat Apron
Disposable Monopolar NeedleElectrodes With Detachable Lead Wire
...igital 32-channel system that is flexible enough t.... It can be set up as a portable EEG system with a...r it can be configured with one of our custom desi...top computer, large,monitor, and laser printer. ...
Medicine Products: